SENSEX NIFTY

Tablets

Nov 20, 2014 at 15:37 | Source: Moneycontrol.com
Dr Reddys Laboratories has launched its over-the-counter Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride Extended Release Tablets 60 mg/ 120 mg, a bioequivalent generic version of Allegra-D 12 Hour Allergy and Congestion, in the US market on November 18, 2014.
Nov 20, 2014 at 04:12 | Source: Reuters
Firefox had 10.4 percent of the US browser market on desktop PCs, mobile smartphones and tablets last month, according to tech data firm StatCounter. Google's Chrome browser was the leader with 33.5 percent.
Nov 17, 2014 at 11:57 | Source: Moneycontrol.com
Veerhealth Care Ltd has informed BSE regarding
Nov 09, 2014 at 12:20 | Source: Moneycontrol.com
At moneycontrol, we take user feedback seriously, and that is also one of the reasons that we have managed to constantly evolve over time
Nov 06, 2014 at 20:13 | Source: PTI
FDA has rescinded the previously granted tentative approvals for Ranbaxy's ANDAs for esomeprazole magnesium delayed-release capsules, 20 mg and 40 mg and for valganciclovir hydrochloride tablets USP, 450 mg, Ranbaxy Laboratories said.
Oct 21, 2014 at 12:18 | Source: Moneycontrol.com
Natco Pharma announced that its marketing partner in the USA, Breckenridge Pharmaceuticals, Inc., has received a tentative approval from the USFDA for Armodafinil 50mg, 150mg and 250mg tablets.
Oct 08, 2014 at 14:01 | Source: Moneycontrol.com
According to Gartner, by year-end 2015, mobile digital assistants will have taken on tactical mundane processes such as filling out names, addresses and credit card information.
Oct 07, 2014 at 08:18 | Source: Reuters
Global shipments of PCs are in for "slow but consistent" growth over the next few years, forecasts tech research firm Gartner, as they recover from three years of declines caused by a surge of tablets and smartphones. But they are still not expected to equal their 2011 peak until 2018 at the earliest.
Sep 18, 2014 at 08:18 | Source: Reuters
Amazon, which entered the hardware sector with the 2007 launch of the Kindle, has adopted a strategy of selling the devices at cost, and it profits when users buy content or goods.
Sep 16, 2014 at 19:07 | Source: CNBC
Four years after Samsung, Apple has finally made its foray into the `phablet` market - a hybrid of a phone and tablet - with the launch of the 4.7-inch iPhone 6 and 5.5-inch iPhone 6 Plus last week. It also unveiled the long-awaited Apple Watch, which won`t be available until 2015.
Messages on Tablets »

madrasan

Silver Member

1 Followers

Shasun Pharma  

a license to sell a generic version of Renvela (sevelamer carbonate) 800-mg tablets beginning March 16, 2014. Impax can also sell oral suspension versions of Renvela and Renagel (sevelamer hydrochloride) beginning September 16, 2014.

12.48 PM Jul 8th

BSE/NSE Announcer

Platinum Member

5246 Followers

Glenmark  

Glenmark Pharmaceuticals Limited has informed the Exchange regarding the press release dated July 08, 2014 titled,"Glenmark Generics receives final ANDA approval for Telmisartan Tablets."

12.41 PM Jul 8th

BSE/NSE Announcer

Platinum Member

5246 Followers

Glenmark  

Glenmark Generics Inc., USA a subsidiary of Glenmark Generics has been granted final abbreviated new drug approval (ANDA) from the United States Food and Drug Administration (US FDA) for Telmisartan Tablets. Glenmark will commence distribution of the product immediately.

12.04 PM Jul 8th

BSE/NSE Announcer

Platinum Member

5246 Followers

Glenmark  

Glenmark Pharmaceuticals Ltd has informed BSE regarding a Press Release dated July 08, 2014 titled "Glenmark Generics receives final ANDA approval for Telmisartan Tablets" Glenmark Generics Inc., USA a subsidiary of Glenmark Generics has been granted final abbreviated new drug approval (ANDA) from

12.04 PM Jul 8th

phs25

Gold Member

9 Followers

Glenmark  

Glenmark Generics receives final ANDA approval for Telmisartan Tablets | 07/08/14 12:01 Glenmark Pharmaceuticals Ltd has informed BSE regarding a Press Release dated July 08, 2014 titled "Glenmark Generics receives final ANDA approval for Telmisartan Tablets

12.03 PM Jul 8th

aindia

Silver Member

168 Followers

Ybrant Digital  

% growth for the first time since 2004, when ad spending increased 6.7%. Mobile will lead this year’s rise in total media ad spending in the US, and advertisers will spend 83.0% more on tablets and smartphones than they did in 2013—an increase of $8.04 billion. By the end of this year, mobile

7.34 PM Jul 2nd

Web Messenger

Platinum Member

252139 Followers

Mobile Tele  

Source:VC Circle - Samsung-Galaxy-Tab-S After unveiling the same last month, Samsung has now launched its Galaxy Tab S range of tablets in the Indian market. The tablets are available in 8.4 and 10.5 inch display screen sizes and according to the company, these are the ...

3.16 PM Jul 2nd

Web Messenger

Platinum Member

252139 Followers

Mobile Tele  

Source:Money Rediff News Report - Sony's flagship tablet - the Xperia Z2 Tablet - after going on sale in some parts of the world, has now become available in India at an online retailer at a price of Rs. 49,990 for its 4G LTE variant. The tablet is also listed on the official website

3.16 PM Jul 2nd

Web Messenger

Platinum Member

252139 Followers

Mobile Tele  

Source:Money Rediff News Report - Korean electronics giant Samsung today launched its new tablet 'Tab S' for Rs 37,800 onwards, to further strengthen its position in the Indian market. The device will be available in two screen sizes - 8.4 inch and 10.5 inch - priced at Rs 37,800 and

3.16 PM Jul 2nd

Web Messenger

Platinum Member

252139 Followers

News Now  

Source:Economic Times - Hybrids and Detachables When Microsoft launched Windows 8 with a touch-optimized interface, a number of manufacturers launched hybrid and detachable devices that offered the benefit of a traditional laptop as well as a tablet. These hybrids are easy to carry around, have

3.12 PM Jul 2nd

Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.